| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| AMGN - Amgen Inc | BUY | 331 @ USD 345.42 | USD 114,334 | The ETF bought 331 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 345.42 compared to the previous average buy price of 295.167. This is 17.0% higher than average price of previous purchases of AMGN. |
| VRTX - Vertex Pharmaceuticals Inc | BUY | 237 @ USD 463.13 | USD 109,762 | The ETF bought 237 new shares of VRTX (Vertex Pharmaceuticals Inc). The shares were bought for an average price of 463.13 compared to the previous average buy price of 417.772. This is 10.9% higher than average price of previous purchases of VRTX. |
| GILD - Guild Esports Plc | BUY | 826 @ USD 125 | USD 103,250 | The ETF bought 826 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 125 compared to the previous average buy price of 114.895. This is 8.8% higher than average price of previous purchases of GILD. |
| REGN - Regeneron Pharmaceuticals Inc | BUY | 111 @ USD 723.67 | USD 80,327 | The ETF bought 111 new shares of REGN (Regeneron Pharmaceuticals Inc). The shares were bought for an average price of 723.67 compared to the previous average buy price of 640.794. This is 12.9% higher than average price of previous purchases of REGN. |
| BIIB - Biogen Inc | BUY | 284 @ USD 180.75 | USD 51,333 | The ETF bought 284 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 180.75 compared to the previous average buy price of 144.66. This is 24.9% higher than average price of previous purchases of BIIB. |
| MRNA - Moderna Inc | BUY | 1,986 @ USD 25.18 | USD 50,007 | The ETF bought 1986 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 25.18 compared to the previous average buy price of 28.4293. This is -11.4% lower than average price of previous purchases of MRNA. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 101.5 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 101.5. The average price that INCY shares were previous bought at was USD 79.054. The current market price is 28.4% higher than average price they were purchased at. The value of the holding in INCY has increased by USD 8,225 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 11.81 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 11.81. The average price that NVCR shares were previous bought at was USD 15.805. The current market price is -25.3% lower than average price they were purchased at. The value of the holding in NVCR has increased by USD 69,178 compared to the previous valuation of Novocure Ltd however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |
| VTRS - Viatris Inc | HOLD | 0 @ USD 10.84 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 10.84. The average price that VTRS shares were previous bought at was USD 9.77225. The current market price is 10.9% higher than average price they were purchased at. The value of the holding in VTRS has increased by USD 106,555 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-12-03 this would crystalise an overall loss. |